Quantum Biopharma Ltd. has announced that on October 31, 2025, it entered into an at the market offering agreement with H.C. Wainwright & Co., LLC for the sale of its Class B Subordinate Voting Shares. This filing is significant for investors as it pertains to their capital-raising efforts.